Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy.
Faget DV, Luo X, Inkman MJ, Ren Q, Su X, Ding K, Waters MR, Raut GK, Pandey G, Dodhiawala PB, Ramalho-Oliveira R, Ye J, Cole T, Murali B, Zheleznyak A, Shokeen M, Weiss KR, Monahan JB, DeSelm CJ, Lee AV, Oesterreich S, Weilbaecher KN, Zhang J, DeNardo DG, Stewart SA. Faget DV, et al. Among authors: waters mr. Cancer Discov. 2023 Jun 2;13(6):1454-1477. doi: 10.1158/2159-8290.CD-22-0907. Cancer Discov. 2023. PMID: 36883955 Free PMC article.
CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer.
Waters M, Price A, Laugeman E, Henke L, Hugo G, Stowe H, Andruska N, Brenneman R, Hao Y, Green O, Robinson C, Gay H, Michalski J, Baumann BC. Waters M, et al. Clin Transl Radiat Oncol. 2023 Oct 24;44:100693. doi: 10.1016/j.ctro.2023.100693. eCollection 2024 Jan. Clin Transl Radiat Oncol. 2023. PMID: 38021093 Free PMC article.
Editorial Comment.
Waters M, Baumann BC. Waters M, et al. J Urol. 2022 Dec;208(6):1238. doi: 10.1097/JU.0000000000002902.02. Epub 2022 Dec 1. J Urol. 2022. PMID: 36349920 No abstract available.
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?
Andruska N, Waters MR, Fischer-Valuck BW, Smith ZL, Kim EH, Reimers M, Brenneman R, Gay HA, Patel SA, Michalski JM, Delacroix SE, Efstathiou JA, Baumann BC. Andruska N, et al. Among authors: waters mr. Clin Genitourin Cancer. 2023 Dec;21(6):653-659.e1. doi: 10.1016/j.clgc.2023.07.011. Epub 2023 Aug 2. Clin Genitourin Cancer. 2023. PMID: 37704483 Clinical Trial.
Survival Outcomes in Men with Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Prostate-Only versus Whole Pelvic Radiation Therapy.
Andruska N, Fischer-Valuck BW, Waters M, Juarez Diaz E, Agabalogun T, Kim EH, Smith ZL, Brenneman RJ, Gay HA, Andriole GL, Michalski JM, Baumann BC. Andruska N, et al. J Urol. 2022 Jun;207(6):1227-1235. doi: 10.1097/JU.0000000000002455. Epub 2022 Jan 27. J Urol. 2022. PMID: 35085038 Free PMC article.
Reply by Authors.
Andruska N, Fischer-Valuck BW, Waters M, Juarez Diaz E, Agabalogun T, Kim EH, Smith ZL, Brenneman RJ, Gay HA, Andriole GL, Michalski JM, Baumann BC. Andruska N, et al. J Urol. 2022 Jun;207(6):1235. doi: 10.1097/JU.0000000000002455.02. Epub 2022 Mar 14. J Urol. 2022. PMID: 35282697 No abstract available.
56 results